about
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?Comparative immunogenomics of molluscs.Lessons from a 15-year-old boy with advanced schistosomiasis japonica in China: a case report.Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni.Paediatric and maternal schistosomiasis: shifting the paradigms.Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4(+)CD25(+)Foxp3(+) regulatory T cells.Epitopes rationally selected through computational analyses induce T-cell proliferation in mice and are recognized by serum from individuals infected with Schistosoma mansoni.The RIO protein kinase-encoding gene Sj-riok-2 is involved in key reproductive processes in Schistosoma japonicum."Omic" investigations of protozoa and worms for a deeper understanding of the human gut "parasitome".Composition of the Schistosoma mansoni worm secretome: Identification of immune modulatory Cyclophilin A.Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni.Influence of Schistosoma japonicum programmed cell death protein 10 on the growth and development of schistosomula.Metazoan Parasite Vaccines: Present Status and Future Prospects.Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.Host Defense Versus Immunosuppression: Unisexual Infection With Male or Female Schistosoma mansoni Differentially Impacts the Immune Response Against Invading Cercariae.Treading the Path towards Genetic Control of Snail Resistance to Schistosome InfectionSchistosome Vaccines for Domestic AnimalsTranscriptomic analysis of male and female Schistosoma mekongi adult worms
P2860
Q37726920-911C86AC-8B80-4A9B-BA7F-7D6033E4AA4AQ38891026-087762D4-D51A-48C7-9C1B-E30F31CF7858Q39308988-8705B5D3-DDEF-4DED-92D6-8E85B5B24D9CQ40045616-9A825F49-0C1D-49A4-9E00-689CE12A8666Q40045772-7735BAEB-1C96-4F24-8265-736812CD5972Q40086105-0CD03E02-DAC2-446F-850F-46650D7AEF62Q40266719-5A3E24B7-06DE-4C86-A61C-59C3A962EEFDQ46242772-A95F757F-47A2-4184-ABE4-9C132FEA7C2BQ46270201-6E571CF5-1849-426B-AB78-F7DE57E78FB8Q47441510-D50B2110-099B-4871-920A-1E6DBCD1FA04Q47551731-6A6D2CBD-DA51-4910-9635-D1247828ACBEQ49309929-4B40C749-2155-4BEF-9BE9-4468DA3E9E01Q55024731-03AE801A-874B-4BDA-B4BC-BB00E91383F3Q55112826-82AAD316-7D0E-4212-B4E3-CEB6E2152601Q55311783-FF037BB2-7FCB-47AB-9A02-743F469CB4EBQ57133713-D8317BC1-3299-47A5-9653-984CD71AC079Q57143698-5C0440B5-AA1D-4023-95B2-6E54CC82D0A9Q57159150-EA9FED28-D854-4518-A5F3-9415CCCE7BEB
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Schistosomiasis vaccines: where do we stand?
@ast
Schistosomiasis vaccines: where do we stand?
@en
Schistosomiasis vaccines: where do we stand?
@nl
type
label
Schistosomiasis vaccines: where do we stand?
@ast
Schistosomiasis vaccines: where do we stand?
@en
Schistosomiasis vaccines: where do we stand?
@nl
prefLabel
Schistosomiasis vaccines: where do we stand?
@ast
Schistosomiasis vaccines: where do we stand?
@en
Schistosomiasis vaccines: where do we stand?
@nl
P2093
P2860
P921
P3181
P1433
P1476
Schistosomiasis vaccines: where do we stand?
@en
P2093
Alex Loukas
Biniam Mathewos Tebeje
Marina Harvie
P2860
P2888
P3181
P356
10.1186/S13071-016-1799-4
P407
P5008
P577
2016-09-30T00:00:00Z
P6179
1012855171